Today: Jul 18, 2019
RU / EN
Last update: Jul 3, 2019
Is There an Optimal Arterial Pressure Level in Patients with End-Stage Chronic Renal Failure Before and After Kidney Transplantation?

Is There an Optimal Arterial Pressure Level in Patients with End-Stage Chronic Renal Failure Before and After Kidney Transplantation?

Fomin I.V., Ostanina А.А., Polyakov D.S., Lipatov K.S.
Keywords: kidney transplantation; end-stage chronic renal failure; arterial hypertension; glomerular filtration rate; antihypertensive therapy.
СТМ, 2014, volume 6, issue 2, pages 53-60.

Full text

html pdf
259
252

Arterial hypertension occurs in 100% cases of end-stage chronic renal failure (ESCRF). It significantly worsens ESCRF and provokes cardiovascular complications. The presence of uncontrolled arterial hypertension after kidney transplantation becomes a determining factor deteriorating the prognosis of patients.

The aim of the investigation was to define the changes of arterial pressure (AP) in patients with end-stage chronic renal failure before and after kidney transplantation, along with antihypertensive therapy, and determine the most safe arterial pressure levels, with the kidney continuing its optimal functioning.

Materials and Methods. The study involved 31 patients (16 male, 15 female patients), who underwent kidney transplantation for ESCRF. The study included the kidney functioning monitoring for a month after the transplantation (5 examinations), and the analysis of hemodynamic, biochemical indices, with transplant function definition. With the aim of achieving optimal AP before and after kidney transplantation, we actively titrated antihypertensive medicinal preparations and studied the functional state of a transplant.

Results. Arterial hypertension was diagnosed in 100% of patients before transplantation; its level decreasing, on average, to the next lower order. In early postoperative period on day 7±1 the patients’ systolic AP decreased from 159.4±13.2/98.7±5.6 to 137.1±9.4/84.8±8.1 mm Hg (p<0.001), and by the time of discharge its level averaged 127.9±9.2/81.1±6.9 mm Hg. Before hospitalization the patients took on average 1.9±0.2 basic medications, on discharge — 2.9±0.1. The indices of creatinine and urea levels, glomerular filtration rate (GFR) and proteinuria consistently normalized. Postoperative intensity of systemic AP decrease had no effect on GFR levels in patients with ESCRF: GFR insignificantly increased in higher systolic AP: R2=0.082; p=0.09; R^2=0.083; p=0.23. A month after kidney transplantation AP level appeared to be optimal in the range of 115–130 mm Hg, and with such AP values GFR indices significantly grew (R2=0.25; p=0.035; R^2=0.3; p=0.027). Diastolic AP level had no significant effect on transplant function.

Conclusion. In 100% cases, ESCRF patients have a syndrome of II or III degree arterial hypertension. After kidney transplantation there is an independent AP increase by one-two AP increase degrees. Intensive AP decrease in ESCRF patients before transplantation results in GFR decline. After transplantation there is GFR increase with an active decrease of systolic AP in the range of 115–130 mm Hg.

  1. Sarnak M.J., Levey A.S. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000; 35(4 Suppl 1): 117–31.
  2. Fox C.S., Larson M.G., Leip E.P., et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844–850, http://dx.doi.org/10.1001/jama.291.7.844.
  3. Rahman M., Pressel S., Davis B.R., Nwachuku C., Wright J.T.Jr., Whelton P.K., Barzilay J., Batuman V., Eckfeldt J.H., Farber M.A., Franklin S., Henriquez M., Kopyt N., Louis G.T., Saklayen M., Stanford C., Walworth C., Ward H., Wiegmann T. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006; 144: 172–180.
  4. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139(2): 137–147, http://dx.doi.org/10.7326/0003-4819-139-2-200307150-00013.
  5. Mange K.C., Feldman H.I., Joffe M.M., et al. Blood pressure and the survival of renal allografts from living donors. J Am Soc Nephrol 2004; 15: 187–193.
  6. Kasiske B.L., Anjum S., Shah R., et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43: 1071–1081.
  7. Opelz G., Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 2005; 5: 2725–2731.
  8. Kasiske B.L. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988; 84: 985–992.
  9. Shlipak M.G., Fried L.F., Cushman M., et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005; 293(14): 1737–1745, http://dx.doi.org/10.1001/jama.293.14.1737.
  10. Ojo A.O. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603–611.
  11. Opelz G., Zeier M., Laux G., et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol 2006; 17(11): 3257–3262, http://dx.doi.org/10.1681/ASN.2006050543.
  12. Heinze G., Mitterbauer C., Regele H., et al. Angiotensin-converting enzyme inhibitor or angiotensin ii type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17(3): 889–899, http://dx.doi.org/10.1681/ASN.2005090955.
  13. Wadei H.M., Amer H., Taler S.J., et al. Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive index. J Am Soc Nephrol 2007; 18(5): 1607–1615, http://dx.doi.org/10.1681/ASN.2006111289.
  14. Haydar A.A., Covic A., Agharazii M., Jayawardene S., Taylor J., Goldsmith D.J. Systolic blood pressure diurnal variation is not a predictor of renal target organ damage in kidney transplant recipients. Am J Transplant 2004; 4(2): 244–247, http://dx.doi.org/10.1046/j.1600-6143.2003.00326.x.
  15. Toprak A., Koc M., Tezcan H., Ozener I.C., Oktay A., Akoglu E. Night-time blood pressure load is associated with higher left ventricular mass index in renal transplant recipients. J Hum Hypertens 2003; 17(4): 239–244, http://dx.doi.org/10.1038/sj.jhh.1001536.
  16. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F. 3rd, Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150(9): 604–612, http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00006.
  17. Zakharova E.V. Problems of diagnosis and conservation therapy of chronic renal disease. Meditsinskiy sovet 2010; 11–12: 47–54.
Fomin I.V., Ostanina А.А., Polyakov D.S., Lipatov K.S. Is There an Optimal Arterial Pressure Level in Patients with End-Stage Chronic Renal Failure Before and After Kidney Transplantation?. Sovremennye tehnologii v medicine 2014; 6(2): 53–60


Journal in Databases

web_of_science.jpg

scopus.jpg

crossref.jpg

doaj.jpg

ebsco.jpg

embase.jpg

ulrich.jpg

cyberleninka.jpg

e-library.jpg

lan.jpg

ajd.jpg

vak.jpg